Analogues of Acifran: Agonists of the high and low affinity niacin receptors, GPR109a and GPR109b

Journal of Medicinal Chemistry

Volumn 50, Issue 7, 2007, Pages 1445-1448

  Jung, Jae Kyu ^a   Johnson, Benjamin R ^a   Duong, Tracy ^a   Decaire, Marc ^a   Uy, Jane ^a   Gharbaoui, Tawfik ^a   Boatman, P Douglas ^a   Sage, Carleton R ^a   Chen, Ruoping ^a   Richman, Jeremy G ^a   Connolly, Daniel T ^a   Semple, Graeme ^a  

^a ARENA PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACIFRAN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 109A; G PROTEIN COUPLED RECEPTOR 109B; HIGH DENSITY LIPOPROTEIN; NICOTINIC ACID RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; REACTION ANALYSIS; RECEPTOR AFFINITY; STRUCTURE ANALYSIS;

CELL LINE; CYCLIC AMP; FURANS; HUMANS; NIACIN; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NICOTINIC; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34147167096     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm070022x     Document Type: Article

References (13)

1. Tavintharan, S.; Kashyap, M. L. The benefits of niacin in atherosclerosis. Curr. Atheroscler. Rep. 2001, 3, 74-82.
2. Carlson, L. A. Nicotinic acid: The broad-spectrum lipid drug. A 50th anniversary review. J. Int. Med. 2005, 258, 94-114.
3. Lorenzen, A.; Stannek, C.; Lang, H.; Andrianov, V.; Kalvinsh, I.; Schwabe, U. Characterization of a G protein-coupled receptor for nicotinic acid. Mol. Pharmacol. 2001, 59, 349-357.
4. Wise, A.; Foord, S. M.; Fraser, N. J.; Barnes, A. A.; Elshourbagy, N.; Eilert, M.; Ignar, D. M.; Murdock, P. R.; Steplewski, K.; Green, A.; Brown, A. J.; Dowell, S. J.; Szekeres, P. G.; Hassall, D. G.; Marshall, F. H.; Wilson, S.; Pike, N. B. Molecular identification of high and low affinity receptors for nicotinic acid. J. Biol. Chem. 2003, 278, 9869-9874.
5. Tunaru, S.; Kero, J.; Schaub, A.; Wufka, C.; Blaukat, A.; Pfeffer, K.; Offermanns, S. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat. Med. (N.Y.) 2003, 9, 352-355.
6. Tunaru, S.; Lättig, J.; Kero, J.; Krause, G.; Offermans, S. Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109a (HM74A/PUMA-G). Mol. Pharmacol. 2005, 68, 1271-1280.
7. Taggart, A. K.; Kero, J.; Gan, X.; Cai, T. Q.; Cheng, K.; Ippolito, M.; Ren, N.; Kaplan, R.; Wu, K.; Wu, T. J.; Jin, L.; Liaw, C.; Chen, R.; Richman, J.; Connolly, D.; Offermanns, S.; Wright, S. D.; Waters, M. G. (D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J Biol.Chem. 2005, 250, 26649-26652.
8. Jirkovsky, I.; Cayen, M. N. Hypolipidemic 4,5-dihydro-4-oxo-5,5- disubstituted-2-furancarboxylic acids. J. Meet. Chem. 1982, 25, 1154-1156.
9. Mahboubi, K.; Witman-Jones, T.; Adamus, J. E.; Letsinger, J. T.; Whitehouse, D.; Moorman, A. R.; Sawicki, D.; Bergenhem, N.; Ross, S. A. Triglyceride modulation by acifran analogs: activity towards the niacin high and low affinity G protein-coupled receptors HM74A and HM74. Biochem. Biophys. Res. Commun. 2006, 340, 482-490.
10. Barrett, A. G. M.; Carr, R. A. E.; Attwood, S. V.; Richardson, G.; Walshe, N. D. A. Total synthesis of (+)-milbemycin beta.3. J. Org. Chem. 1986, 51, 4840-4856.
11. GPR109a and GPR109b receptors with an N-terminal HA tag were cloned into pcDNA3.1 (Invitrogen) and stable cell lines were generated by G418 selection. Positive clones were selected by anti-HA immunostaining. Compound potencies were determined by the 96 well adenylyl cyclase activation FlashPlate assay from Perkin Elmer, as described by the manufacturer. The cAMP assay was optimized for the appropriate receptor stable clone, 5 μM forskolin was used for stimulation and 50 000 cells were used for each well. Positive controls (200%) were defined as cAMP generated by cells without forskolin stimulation and negative controls (100%) were defined as cAMP generated by cells with 5 μM forskolin stimulation.
12. Miyaura, N.; Suzuki, A. Palladium-catalyzed cross-coupling reactions of organoboron compounds. Chem. Rev. 1995, 95, 2457-2483.
13. Semple, G.; Skinner, P. J.; Cherrier, M. C.; Webb, P. J.; Sage, C. R.; Tamura, S. Y.; Chen, R.; Richman, J. G.; Connolly, D. T. 1-Alkyl-benzotriazole- 5-carboxylic acids are highly selective agonists of the human orphan G-protein coupled receptor GPR109b. J. Med Chem. 2006, 49, 1227-1230.